RxSight, Inc. (RXST)
5.95
-0.05
(-0.83%)
USD |
NASDAQ |
May 19, 16:00
6.00
+0.05
(+0.84%)
After-Hours: 20:00
RxSight Research and Development Expense (Quarterly) : 9.472M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Alphatec Holdings, Inc. | 17.56M |
| Teleflex, Inc. | 44.39M |
| Abbott Laboratories | 767.00M |
| AngioDynamics, Inc. | 7.084M |
| Accuray, Inc. | 8.178M |